Top 10 Biologics Approved In 2023

By Adam Tuszyner, Registration Documentation Specialist, Pharmacovigilance Specialist

In the previous year, a significant number of new biologic drugs were approved by regulatory agencies, with 18 approved by the EMA and 34 approved by the FDA. These drugs cover a wide range of therapeutic areas and utilize innovative technologies.

This article highlights 10 of the most important drugs that have the potential to revolutionize medical practice, including protein vaccines against RSV, bispecific antibodies for treatment-resistant cancers, and CRISPR/Cas9-based gene therapy for sickle cell anemia. Access the full article for a brief overview of each drug and its indications.

Additionally, there are expected to be more groundbreaking biologics approved in 2024 that can reshape medical practice and offer hope to patients.